Agencia Lei Va Hong
DKSH

ROCHE HONG KONG LTD

Featured products of Roche
alectinib
Packing/Price
224's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.
bevacizumab
Packing/Price
(single-use) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC07 - bevacizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
atezolizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC32 - atezolizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
atezolizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC32 - atezolizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
baloxavir marboxil
Packing/Price
4's, 2's
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
baloxavir marboxil
Packing/Price
1's, 2's
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
Distributed by Agencia Lei Va Hong
alectinib
Packing/Price
224's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.
bevacizumab
Packing/Price
(single-use) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC07 - bevacizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
atezolizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC32 - atezolizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
atezolizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC32 - atezolizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Distributed by DKSH
alectinib
Packing/Price
224's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.
bevacizumab
Packing/Price
(single-use) 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01XC07 - bevacizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
atezolizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC32 - atezolizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
atezolizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy, Cancer Immunotherapy
ATC Classification
L01XC32 - atezolizumab : Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
baloxavir marboxil
Packing/Price
2's, 4's
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
baloxavir marboxil
Packing/Price
1's, 2's
MIMS Class
Antivirals
ATC Classification
J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in